{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T05:06:59Z","timestamp":1761109619767},"reference-count":20,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2004,6,1]],"date-time":"2004-06-01T00:00:00Z","timestamp":1086048000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Critical Care"],"published-print":{"date-parts":[[2004,6]]},"DOI":"10.1016\/j.jcrc.2004.04.001","type":"journal-article","created":{"date-parts":[[2004,7,6]],"date-time":"2004-07-06T14:21:04Z","timestamp":1089123664000},"page":"75-81","source":"Crossref","is-referenced-by-count":10,"title":["Intravenous immunoglobulin for severe infections: a survey of Canadian specialists"],"prefix":"10.1016","volume":"19","author":[{"given":"Kevin B.","family":"Laupland","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Boucher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Coleman","family":"Rotstein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deborah J.","family":"Cook","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher J.","family":"Doig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcrc.2004.04.001_BIB1","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1056\/NEJMoa022139","article-title":"The epidemiology of sepsis in the United States from 1979 through 2000","volume":"348","author":"Martin","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jcrc.2004.04.001_BIB2","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1093\/clinids\/20.1.143","article-title":"Adjunctive therapy for septic shock","volume":"20","author":"Lynn","year":"1995","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jcrc.2004.04.001_BIB3","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1126\/science.2343314","article-title":"The staphylococcal enterotoxins and their relatives","volume":"248","author":"Marrack","year":"1990","journal-title":"Science"},{"key":"10.1016\/j.jcrc.2004.04.001_BIB4","first-page":"CD001090","article-title":"Intravenous immunoglobulin for treating sepsis and septic shock","volume":"1","author":"Alejandria","year":"2002","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jcrc.2004.04.001_BIB5","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1056\/NEJM200103083441001","article-title":"Efficacy and safety of recombinant human activated protein C for severe sepsis","volume":"344","author":"Bernard","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jcrc.2004.04.001_BIB6","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1056\/NEJM199207233270404","article-title":"Prophylactic intravenous administration of standard immune globulin as compared with core-lipopolysaccharide immune globulin in patients at high risk of postsurgical infection","volume":"327","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jcrc.2004.04.001_BIB7","doi-asserted-by":"crossref","first-page":"2376","DOI":"10.1182\/blood.V90.6.2376","article-title":"Increased in vivo antibody activity against interferon alpha, interleukin-1alpha, and interleukin-6 after high-dose Ig therapy","volume":"90","author":"Ross","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.jcrc.2004.04.001_BIB8","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1155\/2002\/127953","article-title":"Polyclonal intravenous immunoglobulin for the prophylaxis and treatment of infection in critically ill adults","volume":"13","author":"Laupland","year":"2002","journal-title":"Can J Infect Dis"},{"key":"10.1016\/j.jcrc.2004.04.001_BIB9","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1097\/00075198-200110000-00007","article-title":"Intravenous immunoglobulin for prophylaxis and therapy of sepsis","volume":"7","author":"Werdan","year":"2001","journal-title":"Curr Opin Crit Care"},{"key":"10.1016\/j.jcrc.2004.04.001_BIB10","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1086\/515199","article-title":"Intravenous immunoglobulin therapy for streptococcal toxic shock syndrome-A comparative observational study","volume":"28","author":"Kaul","year":"1999","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jcrc.2004.04.001_BIB11","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1086\/376630","article-title":"Intravenous immunoglobulin G therapy in streptococcal toxic shock syndrome","volume":"37","author":"Darenberg","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jcrc.2004.04.001_BIB12","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1007\/978-1-4899-1825-3_130","article-title":"Superantigenic activity produced by group A streptococcal isolates is neutralized by plasma from IVIG-treated streptococcal toxic shock syndrome patients","volume":"418","author":"Norrby-Teglund","year":"1997","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.jcrc.2004.04.001_BIB13","doi-asserted-by":"crossref","first-page":"5395","DOI":"10.1128\/IAI.64.12.5395-5398.1996","article-title":"Evidence for the presence of streptococcal-superantigen-neutralizing antibodies in normal polyspecific immunoglobulin G","volume":"64","author":"Norrby-Teglund","year":"1996","journal-title":"Infect Immun"},{"key":"10.1016\/j.jcrc.2004.04.001_BIB14","doi-asserted-by":"crossref","first-page":"3315","DOI":"10.1001\/jama.267.24.3315","article-title":"Intravenous immunoglobulin therapy for toxic shock syndrome","volume":"267","author":"Barry","year":"1992","journal-title":"JAMA"},{"key":"10.1016\/j.jcrc.2004.04.001_BIB15","first-page":"83","article-title":"Pulmonary and renal toxicity of intravenous immunoglobulin","volume":"36","author":"Rault","year":"1991","journal-title":"Clin Nephrol"},{"key":"10.1016\/j.jcrc.2004.04.001_BIB16","first-page":"347","article-title":"Neurological complications of intravenous immunoglobulin (IVIg) therapy","volume":"98","author":"Mathy","year":"1998","journal-title":"Acta Neurol Belg"},{"key":"10.1016\/j.jcrc.2004.04.001_BIB17","doi-asserted-by":"crossref","first-page":"171","DOI":"10.2165\/00002018-199921030-00003","article-title":"Adverse effects of intravenous immunoglobulin therapy","volume":"21","author":"Nydegger","year":"1999","journal-title":"Drug Saf"},{"key":"10.1016\/j.jcrc.2004.04.001_BIB18","first-page":"1639","article-title":"Does Canada face a crisis? US considers ending plasma exports","volume":"158","author":"Sibbald","year":"1998","journal-title":"Cmaj"},{"key":"10.1016\/j.jcrc.2004.04.001_BIB19","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1086\/514632","article-title":"Invasive group A streptococcal disease in metropolitan Atlanta","volume":"27","author":"Zurawski","year":"1998","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jcrc.2004.04.001_BIB20","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1056\/NEJM199608223350803","article-title":"Invasive group A streptococcal infections in Ontario, Canada","volume":"335","author":"Davies","year":"1996","journal-title":"N Engl J Med"}],"container-title":["Journal of Critical Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S088394410400022X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S088394410400022X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,2]],"date-time":"2020-04-02T13:00:22Z","timestamp":1585832422000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S088394410400022X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,6]]},"references-count":20,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2004,6]]}},"alternative-id":["S088394410400022X"],"URL":"https:\/\/doi.org\/10.1016\/j.jcrc.2004.04.001","relation":{},"ISSN":["0883-9441"],"issn-type":[{"value":"0883-9441","type":"print"}],"subject":[],"published":{"date-parts":[[2004,6]]}}}